Global MRE Adoption Resoundant’s MRE technology is FDA-cleared and installed in over 800 locations worldwide, positioned as an upgrade to MRI scanners from major manufacturers. This indicates strong market demand and a scalable channel to reach hospitals and imaging centers through existing MRI infrastructure.

Strategic Partnerships Recent collaboration with United Imaging Group demonstrates a path to embed MRE capabilities directly into partner OEM MRI platforms, expanding potential sales channels beyond standalone systems to integrated solutions.

Target Liver Fibrosis Current clinical use centers on liver fibrosis with potential expansion into brain, muscle, breast, kidney, spine, and heart. This suggests opportunities to upsell to hospitals expanding MRE-based panels or add-on modules in multidisciplinary imaging programs.

Growth through OEM Upgrades MRE is sold as an upgrade to existing MRI scanners from Philips, GE, and Siemens, offering a low-friction sales proposition to imaging centers looking to enhance diagnostic capabilities without full equipment replacement.

Financial Opportunity With reported revenue in the range of $1M–$10M and a lean team (11–50 employees), there is likely room for scalable deployments, channel partnerships, and regional market expansion to accelerate revenue growth through targeted proposals to mid-to-large imaging centers.